Maleki H, Dorkoosh F, Adabi M, Khosravani M, Arzani H, Kamali M (2017) Methotrexate-loaded plga nanoparticles: preparation, characterization and their cytotoxicity effect on human glioblastoma U87MG cells. Int J Med Nano Res 4(1):020
Arabzadeh A, Mortezazadeh T, Aryafar T, Gharepapagh E, Majdaeen M, Farhood B (2021) Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review. Cancer Cell Int 21(1):1–15
Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS (2021) Brain and other central nervous system tumor statistics. CA: Cancer J Clin 71(5):381–406
Ziyaee S, Malekzadeh R, Ghorbani M, Nasiri Motlagh B, Asghariazar V, Mortezazadeh T (2023) Preparation of MnO2@ poly-(DMAEMA-co-IA)-conjugated methotrexate nano-complex for MRI and radiotherapy of breast cancer application. MAGMA 33(5):779
Mansouri H, Gholibegloo E, Mortezazadeh T, Yazdi MH, Ashouri F, Malekzadeh R et al (2021) A biocompatible theranostic nanoplatform based on magnetic gadolinium-chelated polycyclodextrin: in vitro and in vivo studies. Carbohydr Polym 254:117262
Article CAS PubMed Google Scholar
Zhang L, Liu R, Peng H, Li P, Xu Z, Whittaker AK (2016) The evolution of gadolinium based contrast agents: from single-modality to multi-modality. Nanoscale 8(20):10491–10510
Article CAS PubMed Google Scholar
Han C, Xie T, Wang K, Jin S, Li K, Dou P et al (2020) Development of fluorescence/MR dual-modal manganese-nitrogen-doped carbon nanosheets as an efficient contrast agent for targeted ovarian carcinoma imaging. J Nanobiotechnology 18:1–15
Liang S, Liao G, Zhu W, Zhang L (2022) Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies. Biomater Res 26(1):1–21
Haque S, Tripathy S, Patra CR (2021) Manganese-based advanced nanoparticles for biomedical applications: future opportunity and challenges. Nanoscale 13(39):16405–16426
Article CAS PubMed Google Scholar
Cai X, Zhu Q, Zeng Y, Zeng Q, Chen X, Zhan Y (2019) Manganese oxide nanoparticles as MRI contrast agents in tumor multimodal imaging and therapy. Int J Nanomed 14:8321–8344
Khalilnejad M, Mortezazadeh T, Shayan RG (2021) Application of Manganese Oxide (MnO) nanoparticles in multimodal molecular imaging and cancer therapy: a review. Nanomed J 8:166–178
Wu J, Wang M, Pan Y, Pang Y, Tang Y, Song C et al (2022) Synthesis of manganese-oxide and palladium nanoparticles co-decorated polypyrrole/graphene oxide (MnO 2@ Pd@ PPy/GO) nanocomposites for anti-cancer treatment. RSC Adv 12(37):23786–23795
Article CAS PubMed PubMed Central Google Scholar
Zhuang D, Zhang H, Hu G, Guo B (2022) Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma. J Nanobiotechnology 20(1):1–21
Jalili-Nik M, Abbasinezhad-Moud F, Sahab-Negah S, Maghrouni A, Etezad Razavi M, Khaleghi Ghadiri M et al (2021) Antitumor effects of 5-Aminolevulinic acid on human malignant glioblastoma cells. Int J Mol Sci 22(11):5596
Article CAS PubMed PubMed Central Google Scholar
Harada Y, Murayama Y, Takamatsu T, Otsuji E, Tanaka H (2022) 5-aminolevulinic acid-induced protoporphyrin IX fluorescence imaging for tumor detection: Recent advances and challenges. Int J Mol Sci 23(12):6478
Article CAS PubMed PubMed Central Google Scholar
Ebrahimpour A, Riahi Alam N, Khoobi M (2021) The potential of 5-aminolevulinic acid as a contrast agent in MR imaging: challenges and opportunities. Jsciences 32(1):15–28
Gholibegloo E, Mortezazadeh T, Salehian F, Forootanfar H, Firoozpour L, Foroumadi A et al (2019) Folic acid decorated magnetic nanosponge: an efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging. J Colloid Interface Sci 556:128–139
Article CAS PubMed Google Scholar
Lodhi MS, Khalid F, Khan MT, Samra ZQ, Muhammad S, Zhang Y-J, Mou K (2022) A novel method of magnetic nanoparticles functionalized with anti-folate receptor antibody and methotrexate for antibody mediated targeted drug delivery. Molecules 27(1):261
Article CAS PubMed PubMed Central Google Scholar
Narmani A, Farhood B, Haghi-Aminjan H, Mortezazadeh T, Aliasgharzadeh A, Mohseni M et al (2018) Gadolinium nanoparticles as diagnostic and therapeutic agents: their delivery systems in magnetic resonance imaging and neutron capture therapy. J Drug Deliv Sci Technol 44:457–466
Chen H, He J (2008) Facile synthesis of monodisperse manganese oxide nanostructures and their application in water treatment. J Phys Chem C 112(45):17540–17545
Dastgir M, Ayyami Y, Pourfarshid A, Ghorbani M, Mortezazadeh T (2024) Evaluation of the theranostic characteristics of chitosan-decorated bismuth oxide nanoparticles conjugated curcumin and 5-aminolevulinic acid as a biocompatible targeted nanoplatform in CT and breast cancer radiation therapy. J Drug Deliv Technol 92:105279
Abhari F, Charmi J, Rezaeejam H, Karimimoghaddam Z, Nosrati H, Danafar H, Farajollahi A (2020) Folic acid modified bismuth sulfide and gold heterodimers for enhancing radiosensitization of mice tumors to X-ray radiation. ACS Sustain Chem Eng 8(13):5260–5269
Makhlof A, Werle M, Tozuka Y, Takeuchi H (2011) A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. JCR 149(1):81–88
Mortezazadeh T, Gholibegloo E, Haghgoo S, Musa A, Khoobi M (2020) Glucosamine conjugated gadolinium (III) oxide nanoparticles as a novel targeted contrast agent for cancer diagnosis in MRI. JBPE 10(1):25
Jeon M, Halbert MV, Stephen ZR, Zhang M (2021) Iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging: fundamentals, challenges, applications, and prospectives. Adv Mater 33(23):1906539
Hong JY, Lim YG, Song YJ, Park K (2023) Tumor microenvironment-responsive histidine modified-hyaluronic acid-based MnO2 as in vivo MRI contrast agent. Int J Biol Macromol 226:121–131
Article CAS PubMed Google Scholar
Fu C, Duan X, Cao M, Jiang S, Ban X, Guo N et al (2019) Targeted magnetic resonance imaging and modulation of hypoxia with multifunctional hyaluronic acid-MnO2 nanoparticles in glioma. Adv Healthc Mater 8(10):1900047
Wang X, Li S, Liu H (2021) Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas. Photodiagn Photodyn Ther 34:102218
Xu R, Wang X, Wang D, Zhou K, Li Y (2006) Surface structure effects in nanocrystal MnO2 and Ag/MnO2 catalytic oxidation of CO. J Catal 237(2):426–430
Abdollahi BB, Ghorbani M, Hamishehkar H, Malekzadeh R, Farajollahi A (2023) Synthesis and characterization of actively HER-2 Targeted Fe3O4@ Au nanoparticles for molecular radiosensitization of breast cancer. Bioimpacts 13(1):17
Kefayat A, Ghahremani F, Motaghi H, Amouheidari A (2019) Ultra-small but ultra-effective: folic acid-targeted gold nanoclusters for enhancement of intracranial glioma tumors’ radiation therapy efficacy. NBM 16:173–184
Park M, Lee N, Choi SH, An K, Yu S-H, Kim JH et al (2011) Large-scale synthesis of ultrathin manganese oxide nanoplates and their applications to T1 MRI contrast agents. Chem Mater 23(14):3318–3324
Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338(2):284–293
Article CAS PubMed Google Scholar
Chen Y, Chen H, Zhang S, Chen F, Sun S, He Q et al (2012) Structure-property relationships in manganese oxide-mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery. Biomater 33(7):2388–2398
Li L, Gao F, Jiang W, Wu X, Cai Y, Tang J et al (2016) Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging. Drug deliv 23(5):1726–1733
Comments (0)